6934 — Hcmed Innovations Co Share Price
Last trade - 00:00- TWD4.24bn
- TWD4.06bn
- TWD141.61m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 15.88 | ||
| Price to Tang. Book | 15.93 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 29.92 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -17.21% | ||
| Return on Equity | -32.46% | ||
| Operating Margin | -38.6% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | n/a | 54.05 | 6.48 | 9.23 | 141.61 | n/a | n/a | 37.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hcmed Innovations Co Ltd is a Taiwan-based company mainly provides design/development/production/sales services based on handheld medical nebulizers in accordance with the needs of pharmaceutical companies. The products mainly include vibrating mesh nebulizers and contract development and manufacturing organization (CDMO) services for drug-specific nebulizers. The vibrating mesh nebulizer can adjust the oscillation frequency of the retina for different types of drugs, so that patients can successfully deliver drugs to the lower respiratory tract without training and specific breathing methods. The vibrating mesh nebulizer can be used to treat diseases such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and respiratory tract infections. The CDMO service for drug-specific nebulizers provides special nebulizers for inhalation dosage form design and development. The products are mainly sold in the United States, Taiwan, Switzerland, Israel, and the United Kingdom.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- October 6th, 2014
- Public Since
- June 25th, 2024
- No. of Employees
- 49
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 32,716,800
- Address
- Room B, 10F, TAIPEI, 106
- Web
- https://www.hcmed-inno.com/
- Phone
- +886 227326596
- Contact
- Wei-Cheng Tu
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 6934
Similar to 6934
Apex Biotechnology
Taiwan Stock Exchange
Wellell
Taiwan Stock Exchange
A Plus Biotechnology Co
Taiwan Stock Exchange
Bionime
Taiwan Stock Exchange
Bonraybio Co
Taiwan Stock Exchange
FAQ
As of Today at 20:03 UTC, shares in Hcmed Innovations Co are trading at TWD129.50. This share price information is delayed by 15 minutes.
Shares in Hcmed Innovations Co last closed at TWD129.50 and the price had moved by +76.67% over the past 365 days. In terms of relative price strength the Hcmed Innovations Co share price has outperformed the FTSE Developed Asia Pacific Index by +16.1% over the past year.
There is no consensus recommendation for this security.
Find out moreHcmed Innovations Co does not currently pay a dividend.
Hcmed Innovations Co does not currently pay a dividend.
Hcmed Innovations Co does not currently pay a dividend.
To buy shares in Hcmed Innovations Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TWD129.50, shares in Hcmed Innovations Co had a market capitalisation of TWD4.24bn.
Here are the trading details for Hcmed Innovations Co:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6934
Based on an overall assessment of its quality, value and momentum Hcmed Innovations Co is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hcmed Innovations Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +50.68%.
As of the last closing price of TWD129.50, shares in Hcmed Innovations Co were trading +75.25% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hcmed Innovations Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD129.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Hcmed Innovations Co's directors